NO175870B - - Google Patents

Download PDF

Info

Publication number: NO175870B
Authority: NO; Norway
Prior art keywords: polypeptide; gene; cecropin; arab; sequence
Prior art date: 1985-01-28

Application number

NO863806A

Other languages

English (en)

Norwegian (no)

Other versions

NO175870C (no

NO863806L (no

NO863806D0 (no

Original Assignee

Xoma Corp

Int Genetic Eng

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-01-28

Filing date

1986-09-24

Publication date

1994-09-12

1986-09-24 Application filed by Xoma Corp, Int Genetic Eng filed Critical Xoma Corp

1986-09-24 Publication of NO863806D0 publication Critical patent/NO863806D0/no

1986-11-19 Publication of NO863806L publication Critical patent/NO863806L/no

1994-09-12 Publication of NO175870B publication Critical patent/NO175870B/no

1994-12-21 Publication of NO175870C publication Critical patent/NO175870C/no

Links

108090000623 proteins and genes Proteins 0.000 claims abstract description 123
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 110
108050004290 Cecropin Proteins 0.000 claims abstract description 95
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 94
229920001184 polypeptide Polymers 0.000 claims abstract description 88
241000894006 Bacteria Species 0.000 claims abstract description 22
108091033319 polynucleotide Proteins 0.000 claims abstract description 12
102000040430 polynucleotide Human genes 0.000 claims abstract description 12
239000002157 polynucleotide Substances 0.000 claims abstract description 12
239000013612 plasmid Substances 0.000 claims description 83
238000000034 method Methods 0.000 claims description 41
102000004169 proteins and genes Human genes 0.000 claims description 36
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 30
SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 29
238000003776 cleavage reaction Methods 0.000 claims description 26
230000007017 scission Effects 0.000 claims description 26
239000013604 expression vector Substances 0.000 claims description 19
238000004519 manufacturing process Methods 0.000 claims description 16
230000004927 fusion Effects 0.000 claims description 15
230000001580 bacterial effect Effects 0.000 claims description 13
239000002609 medium Substances 0.000 claims description 11
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 10
239000002243 precursor Substances 0.000 claims description 9
102000004190 Enzymes Human genes 0.000 claims description 8
108090000790 Enzymes Proteins 0.000 claims description 8
239000001963 growth medium Substances 0.000 claims description 8
101710172711 Structural protein Proteins 0.000 claims description 6
-1 antibody Proteins 0.000 claims description 6
229940088597 hormone Drugs 0.000 claims description 6
239000005556 hormone Substances 0.000 claims description 6
102000004877 Insulin Human genes 0.000 claims description 5
108090001061 Insulin Proteins 0.000 claims description 5
102000015696 Interleukins Human genes 0.000 claims description 5
108010063738 Interleukins Proteins 0.000 claims description 5
229940125396 insulin Drugs 0.000 claims description 5
102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 4
108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 4
230000008569 process Effects 0.000 claims description 4
229960000187 tissue plasminogen activator Drugs 0.000 claims description 4
102000001554 Hemoglobins Human genes 0.000 claims description 3
108010054147 Hemoglobins Proteins 0.000 claims description 3
108010050904 Interferons Proteins 0.000 claims description 3
102000014150 Interferons Human genes 0.000 claims description 3
NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 claims description 3
102000009618 Transforming Growth Factors Human genes 0.000 claims description 3
108010009583 Transforming Growth Factors Proteins 0.000 claims description 3
230000001131 transforming effect Effects 0.000 claims description 3
KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 claims description 2
UKGGPJNBONZZCM-WDSKDSINSA-N Asp-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O UKGGPJNBONZZCM-WDSKDSINSA-N 0.000 claims description 2
101000741445 Homo sapiens Calcitonin Proteins 0.000 claims description 2
102000006992 Interferon-alpha Human genes 0.000 claims description 2
108010047761 Interferon-alpha Proteins 0.000 claims description 2
102000003996 Interferon-beta Human genes 0.000 claims description 2
108090000467 Interferon-beta Proteins 0.000 claims description 2
102000008070 Interferon-gamma Human genes 0.000 claims description 2
108010074328 Interferon-gamma Proteins 0.000 claims description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
108010093581 aspartyl-proline Proteins 0.000 claims description 2
229940044627 gamma-interferon Drugs 0.000 claims description 2
229940045644 human calcitonin Drugs 0.000 claims description 2
229940079322 interferon Drugs 0.000 claims description 2
241001515965 unidentified phage Species 0.000 claims 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract description 30
230000000844 anti-bacterial effect Effects 0.000 abstract description 25
108020001507 fusion proteins Proteins 0.000 abstract description 20
102000037865 fusion proteins Human genes 0.000 abstract description 20
230000002068 genetic effect Effects 0.000 abstract description 10
101150097746 araB gene Proteins 0.000 description 63
239000012634 fragment Substances 0.000 description 42
101800003223 Cecropin-A Proteins 0.000 description 40
241000588724 Escherichia coli Species 0.000 description 39
210000004027 cell Anatomy 0.000 description 35
235000018102 proteins Nutrition 0.000 description 34
238000010276 construction Methods 0.000 description 32
239000000047 product Substances 0.000 description 32
HCQPHKMLKXOJSR-IRCPFGJUSA-N cecropin-a Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C1=CC=CC=C1 HCQPHKMLKXOJSR-IRCPFGJUSA-N 0.000 description 30
108020004414 DNA Proteins 0.000 description 25
235000001014 amino acid Nutrition 0.000 description 21
150000001413 amino acids Chemical class 0.000 description 18
230000015572 biosynthetic process Effects 0.000 description 15
238000013518 transcription Methods 0.000 description 13
230000035897 transcription Effects 0.000 description 13
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
108020004705 Codon Proteins 0.000 description 12
125000003275 alpha amino acid group Chemical group 0.000 description 12
230000000694 effects Effects 0.000 description 12
108091008146 restriction endonucleases Proteins 0.000 description 11
241000894007 species Species 0.000 description 11
230000012010 growth Effects 0.000 description 10
108020004999 messenger RNA Proteins 0.000 description 10
239000002773 nucleotide Substances 0.000 description 10
125000003729 nucleotide group Chemical group 0.000 description 10
108060001064 Calcitonin Proteins 0.000 description 9
108010042407 Endonucleases Proteins 0.000 description 9
102000004533 Endonucleases Human genes 0.000 description 9
238000000855 fermentation Methods 0.000 description 9
230000004151 fermentation Effects 0.000 description 9
238000005457 optimization Methods 0.000 description 9
238000003786 synthesis reaction Methods 0.000 description 9
239000013598 vector Substances 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
240000004808 Saccharomyces cerevisiae Species 0.000 description 8
210000003000 inclusion body Anatomy 0.000 description 8
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 8
108091033411 PCA3 Proteins 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 7
238000004128 high performance liquid chromatography Methods 0.000 description 7
230000001939 inductive effect Effects 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
241001288713 Escherichia coli MC1061 Species 0.000 description 6
101100353526 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pca-2 gene Proteins 0.000 description 6
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 6
229960000723 ampicillin Drugs 0.000 description 6
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
108700003859 araC Genes Proteins 0.000 description 6
101150044616 araC gene Proteins 0.000 description 6
229960004015 calcitonin Drugs 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
230000029087 digestion Effects 0.000 description 6
239000000203 mixture Substances 0.000 description 6
102000039446 nucleic acids Human genes 0.000 description 6
108020004707 nucleic acids Proteins 0.000 description 6
150000007523 nucleic acids Chemical class 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
102000055006 Calcitonin Human genes 0.000 description 5
101150035354 araA gene Proteins 0.000 description 5
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
238000010367 cloning Methods 0.000 description 5
125000001475 halogen functional group Chemical group 0.000 description 5
230000000813 microbial effect Effects 0.000 description 5
239000001301 oxygen Substances 0.000 description 5
229910052760 oxygen Inorganic materials 0.000 description 5
239000008188 pellet Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
101100002068 Bacillus subtilis (strain 168) araR gene Proteins 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
241000701959 Escherichia virus Lambda Species 0.000 description 4
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
241000589516 Pseudomonas Species 0.000 description 4
108020004511 Recombinant DNA Proteins 0.000 description 4
238000012300 Sequence Analysis Methods 0.000 description 4
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
239000012190 activator Substances 0.000 description 4
125000000539 amino acid group Chemical group 0.000 description 4
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
239000000872 buffer Substances 0.000 description 4
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 4
235000019253 formic acid Nutrition 0.000 description 4
239000000499 gel Substances 0.000 description 4
229930182817 methionine Natural products 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
239000008363 phosphate buffer Substances 0.000 description 4
239000013587 production medium Substances 0.000 description 4
239000000523 sample Substances 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
238000013519 translation Methods 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
241000238631 Hexapoda Species 0.000 description 3
241000256023 Hyalophora cecropia Species 0.000 description 3
108700032080 Hyalophora cecropia cecropin D Proteins 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
239000004098 Tetracycline Substances 0.000 description 3
239000002253 acid Substances 0.000 description 3
238000005273 aeration Methods 0.000 description 3
101150017736 araD gene Proteins 0.000 description 3
230000008859 change Effects 0.000 description 3
239000007857 degradation product Substances 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000011534 incubation Methods 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
239000008101 lactose Substances 0.000 description 3
239000002207 metabolite Substances 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
239000012071 phase Substances 0.000 description 3
238000000746 purification Methods 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
230000003362 replicative effect Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
108020002667 ribulokinase Proteins 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
229960002180 tetracycline Drugs 0.000 description 3
229930101283 tetracycline Natural products 0.000 description 3
235000019364 tetracycline Nutrition 0.000 description 3
150000003522 tetracyclines Chemical class 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
241000255978 Antheraea pernyi Species 0.000 description 2
241000194107 Bacillus megaterium Species 0.000 description 2
125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
241001299678 Cecropia Species 0.000 description 2
241000588923 Citrobacter Species 0.000 description 2
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
241000588698 Erwinia Species 0.000 description 2
108700022013 Insecta cecropin B Proteins 0.000 description 2
108010018080 L-arabinose isomerase Proteins 0.000 description 2
ZAQJHHRNXZUBTE-UCORVYFPSA-N L-ribulose Chemical compound OC[C@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-UCORVYFPSA-N 0.000 description 2
FNZLKVNUWIIPSJ-CRCLSJGQSA-N L-ribulose 5-phosphate Chemical compound OCC(=O)[C@@H](O)[C@@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-CRCLSJGQSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
108010036176 Melitten Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
108700005075 Regulator Genes Proteins 0.000 description 2
241000607142 Salmonella Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 2
241000589634 Xanthomonas Species 0.000 description 2
230000009471 action Effects 0.000 description 2
238000013019 agitation Methods 0.000 description 2
OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 description 2
102000005936 beta-Galactosidase Human genes 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000013599 cloning vector Substances 0.000 description 2
238000004590 computer program Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
238000005304 joining Methods 0.000 description 2
239000003550 marker Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 2
230000035772 mutation Effects 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
230000001323 posttranslational effect Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000012743 protein tagging Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000002741 site-directed mutagenesis Methods 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000003643 water by type Substances 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
VKIGAWAEXPTIOL-UHFFFAOYSA-N 2-hydroxyhexanenitrile Chemical compound CCCCC(O)C#N VKIGAWAEXPTIOL-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
101100325906 Bacillus subtilis (strain 168) ganA gene Proteins 0.000 description 1
101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 description 1
101100350224 Bacillus subtilis (strain 168) pdhB gene Proteins 0.000 description 1
241000255789 Bombyx mori Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
241000193155 Clostridium botulinum Species 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108010073254 Colicins Proteins 0.000 description 1
101100236536 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) glcB gene Proteins 0.000 description 1
PPQRONHOSHZGFQ-VPENINKCSA-N D-xylose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-VPENINKCSA-N 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
101000856051 Doratifera vulnerans DELTA-limacoditoxin(2)-Dv11 Proteins 0.000 description 1
101000856052 Doratifera vulnerans DELTA-limacoditoxin(2)-Dv12 Proteins 0.000 description 1
101000939431 Doratifera vulnerans U-limacoditoxin(13)-Dv73 Proteins 0.000 description 1
101000844428 Doratifera vulnerans U-limacoditoxin(3)-Dv21 Proteins 0.000 description 1
101000844426 Doratifera vulnerans U-limacoditoxin(3)-Dv33 Proteins 0.000 description 1
101000808775 Doratifera vulnerans U-limacoditoxin(7)-Dv63 Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
241000588921 Enterobacteriaceae Species 0.000 description 1
241000251852 Enterococcus pernyi Species 0.000 description 1
241001646716 Escherichia coli K-12 Species 0.000 description 1
241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
101150088008 HCT gene Proteins 0.000 description 1
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 description 1
108090000416 L-ribulose-5-phosphate 4-epimerases Proteins 0.000 description 1
241000186660 Lactobacillus Species 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
241000191938 Micrococcus luteus Species 0.000 description 1
102100030856 Myoglobin Human genes 0.000 description 1
108010062374 Myoglobin Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
241000283222 Physeter catodon Species 0.000 description 1
102000001938 Plasminogen Activators Human genes 0.000 description 1
108010001014 Plasminogen Activators Proteins 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 description 1
101100406344 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceF gene Proteins 0.000 description 1
101100408135 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnA gene Proteins 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
108090001066 Racemases and epimerases Proteins 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
241000405383 Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
241000607720 Serratia Species 0.000 description 1
241000607715 Serratia marcescens Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
241000194019 Streptococcus mutans Species 0.000 description 1
101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 1
108700005078 Synthetic Genes Proteins 0.000 description 1
101100111413 Thermoanaerobacter pseudethanolicus (strain ATCC 33223 / 39E) lacZ gene Proteins 0.000 description 1
JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
241001672648 Vieira Species 0.000 description 1
201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
241000607735 Xenorhabdus nematophila Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
101150094017 aceA gene Proteins 0.000 description 1
101150036393 aceB gene Proteins 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
101150118463 argG gene Proteins 0.000 description 1
101150090235 aroB gene Proteins 0.000 description 1
238000003556 assay Methods 0.000 description 1
101150070136 axeA gene Proteins 0.000 description 1
239000003659 bee venom Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
108010009896 bone resorption factor Proteins 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000004075 cariostatic agent Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
101150034144 ci gene Proteins 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000002781 deodorant agent Substances 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
239000003480 eluent Substances 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000012262 fermentative production Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
230000006870 function Effects 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000008348 humoral response Effects 0.000 description 1
AFQIYTIJXGTIEY-UHFFFAOYSA-N hydrogen carbonate;triethylazanium Chemical compound OC(O)=O.CCN(CC)CC AFQIYTIJXGTIEY-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000000121 hypercalcemic effect Effects 0.000 description 1
230000001184 hypocalcaemic effect Effects 0.000 description 1
150000003949 imides Chemical class 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000003999 initiator Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
101150086432 lacA gene Proteins 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
238000009629 microbiological culture Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
IFPHDUVGLXEIOQ-UHFFFAOYSA-N ortho-iodosylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1I=O IFPHDUVGLXEIOQ-UHFFFAOYSA-N 0.000 description 1
230000011164 ossification Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
108010083127 phage repressor proteins Proteins 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
229940127126 plasminogen activator Drugs 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000002028 premature Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
150000003140 primary amides Chemical class 0.000 description 1
235000020991 processed meat Nutrition 0.000 description 1
238000012545 processing Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
238000000734 protein sequencing Methods 0.000 description 1
101150002764 purA gene Proteins 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
OENLEHTYJXMVBG-UHFFFAOYSA-N pyridine;hydrate Chemical compound [OH-].C1=CC=[NH+]C=C1 OENLEHTYJXMVBG-UHFFFAOYSA-N 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000004044 response Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
235000019157 thiamine Nutrition 0.000 description 1
229960003495 thiamine Drugs 0.000 description 1
239000011721 thiamine Substances 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
150000005691 triesters Chemical class 0.000 description 1
101150019416 trpA gene Proteins 0.000 description 1
101150081616 trpB gene Proteins 0.000 description 1
101150111232 trpB-1 gene Proteins 0.000 description 1
101150016309 trpC gene Proteins 0.000 description 1
101150100816 trpD gene Proteins 0.000 description 1
101150044170 trpE gene Proteins 0.000 description 1
101150079930 trpGD gene Proteins 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
230000004614 tumor growth Effects 0.000 description 1
101150083154 tyrA gene Proteins 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Toxicology (AREA)
Medicinal Chemistry (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Tropical Medicine & Parasitology (AREA)
Insects & Arthropods (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

NO863806A 1985-01-28 1986-09-24 Replikerbar ekspresjonsvektor og fremgangsmåte for fremstilling av et biologisk aktivt heterologt polypeptid NO175870C (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US69530985A	1985-01-28	1985-01-28
US79747285A	1985-11-13	1985-11-13
PCT/US1986/000131 WO1986004356A1 (fr)	1985-01-28	1986-01-24	PROMOTEURS D'araB ET PROCEDE DE PRODUCTION DE POLYPEPTIDES, Y COMPRIS DES CECROPINES, PAR DES TECHNIQUES MICROBIOLOGIQUES

Publications (4)

Publication Number	Publication Date
NO863806D0 NO863806D0 (no)	1986-09-24
NO863806L NO863806L (no)	1986-11-19
NO175870B true NO175870B (fr)	1994-09-12
NO175870C NO175870C (no)	1994-12-21

Family

ID=27105550

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO863806A NO175870C (no)	1985-01-28	1986-09-24	Replikerbar ekspresjonsvektor og fremgangsmåte for fremstilling av et biologisk aktivt heterologt polypeptid

Country Status (8)

Country	Link
EP (2)	EP0211047B1 (fr)
JP (2)	JPH082308B2 (fr)
KR (1)	KR870700095A (fr)
AT (2)	ATE101203T1 (fr)
DE (2)	DE3689598T2 (fr)
FI (1)	FI94774C (fr)
NO (1)	NO175870C (fr)
WO (1)	WO1986004356A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5166321A (en) *	1985-01-28	1992-11-24	International Genetic Engineering, Inc.	Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria
US5028530A (en) *	1985-01-28	1991-07-02	Xoma Corporation	AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
US5597945A (en) *	1986-07-25	1997-01-28	Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Plants genetically enhanced for disease resistance
EP0590301A2 (fr) *	1986-07-25	1994-04-06	Louisiana State University and Agricultural and Mechanical College	Méthode de protection des plantes contre des maladies et l'infestation par insertion de gène et vecteurs et cellules végétales contenant les gènes
DE3716957A1 (de) *	1987-05-20	1988-12-01	Boehringer Mannheim Gmbh	Expressionsvektor zur regulierbaren expression von fremdgenen in prokaryonten
US5861478A (en) *	1987-07-06	1999-01-19	Helix Biomedix, Inc.	Lytic peptides
WO1989000194A1 (fr) *	1987-07-06	1989-01-12	Louisiana State University Agricultural And Mechan	Inhibition de pathogenes et de neoplasmes eucaryotiques, et stimulation de fibroblastes et de lymphocytes avec des peptides lytiques
CA1327311C (fr) *	1987-07-06	1994-03-01	Jesse M. Jaynes	Polypeptides antimicrobiens therapeutiques, leurs methodes de preparation et leurs usages
EP0326419A3 (fr) *	1988-01-27	1991-09-25	THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE	Vaccins pour la protection des animaux contre l'hypodermose
PH30997A (en) *	1990-03-12	1997-12-23	Ciba Geigy	Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
US5631007A (en) *	1990-03-12	1997-05-20	Ciba-Geigy Corporation	Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes
IL114697A0 (en) *	1994-07-22	1995-11-27	Demeter Biotech Ltd	Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
US5589364A (en) *	1994-07-29	1996-12-31	Magainin Pharmaceuticals Inc.	Recombinant production of biologically active peptides and proteins
GB9610967D0 (en)	1996-05-24	1996-07-31	Cambridge Antibody Tech	Specific binding members,materials and methods
US6030807A (en) *	1996-09-10	2000-02-29	The Rockefeller University	Highly regulable promoter for heterologous gene expression
JP2003524018A (ja)	2000-02-24	2003-08-12	アイトゲネーシシェテクニシェホッホシューレチューリッヒ	フィブロネクチンのｅｄ‐ｂドメインに特異的な抗体、前記抗体を含む複合体、および血管形成を検出および治療するためのその使用
CA2589937C (fr)	2004-12-07	2014-04-22	Lonza Ag	Systeme d'expression du promoteur de rhamnose
EP4282419A1 (fr)	2012-12-20	2023-11-29	Purdue Research Foundation	Cellules t exprimant un récepteur d'antigène chimérique et produits thérapeutiques anticancéreux
EP3439675A4 (fr)	2016-04-08	2019-12-18	Purdue Research Foundation	Méthodes et compositions pour thérapie par lymphocytes t car
US11649288B2 (en)	2017-02-07	2023-05-16	Seattle Children's Hospital	Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
WO2018160622A1 (fr)	2017-02-28	2018-09-07	Endocyte, Inc.	Compositions et méthodes de thérapie par lymphocytes t car
US11311576B2 (en)	2018-01-22	2022-04-26	Seattle Children's Hospital	Methods of use for CAR T cells
US12312416B2 (en)	2018-02-06	2025-05-27	Seattle Children's Hospital	Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors
AU2019225174B2 (en)	2018-02-23	2025-11-20	Endocyte, Inc.	Sequencing method for CAR T cell therapy
CN115210252A (zh)	2020-02-04	2022-10-18	西雅图儿童医院（Dba西雅图儿童研究所）	抗二硝基苯酚的嵌合抗原受体
CN112575047B (zh) *	2020-12-29	2024-06-21	中农颖泰林州生物科园有限公司	一种提高饲料用的抗菌肽天蚕素收率的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4366246A (en)	1977-11-08	1982-12-28	Genentech, Inc.	Method for microbial polypeptide expression
US4335104A (en) *	1978-08-16	1982-06-15	United Chemical Corporation	Anhydrous multi-purpose moisturizing composition
ZA811368B (en)	1980-03-24	1982-04-28	Genentech Inc	Bacterial polypedtide expression employing tryptophan promoter-operator
US4355104A (en)	1980-06-17	1982-10-19	Kabigen Ab	Bacteriolytic proteins
US4520016A (en) *	1980-06-17	1985-05-28	Kabigen Ab	Bacteriolytic proteins
GR79202B (fr)	1982-05-05	1984-10-22	Genentech Inc
AU577334B2 (en) *	1983-10-11	1988-09-22	International Genetic Engineering, Inc.	Synthetic thaumatin genes

1986
- 1986-01-24 AT AT86900983T patent/ATE101203T1/de not_active IP Right Cessation
- 1986-01-24 JP JP61500818A patent/JPH082308B2/ja not_active Expired - Lifetime
- 1986-01-24 KR KR1019860700669A patent/KR870700095A/ko not_active Ceased
- 1986-01-24 EP EP86900983A patent/EP0211047B1/fr not_active Expired - Lifetime
- 1986-01-24 DE DE3689598T patent/DE3689598T2/de not_active Expired - Lifetime
- 1986-01-24 EP EP91112901A patent/EP0460709B1/fr not_active Expired - Lifetime
- 1986-01-24 AT AT91112901T patent/ATE153377T1/de not_active IP Right Cessation
- 1986-01-24 WO PCT/US1986/000131 patent/WO1986004356A1/fr not_active Ceased
- 1986-01-24 DE DE3650625T patent/DE3650625T2/de not_active Expired - Fee Related
- 1986-09-24 NO NO863806A patent/NO175870C/no unknown
- 1986-09-26 FI FI863891A patent/FI94774C/fi not_active IP Right Cessation
1994
- 1994-05-09 JP JP6094753A patent/JPH0829112B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO175870C (no)	1994-12-21
EP0211047A1 (fr)	1987-02-25
ATE153377T1 (de)	1997-06-15
FI94774B (fi)	1995-07-14
EP0211047A4 (fr)	1989-04-24
JPH0829112B2 (ja)	1996-03-27
FI863891A0 (fi)	1986-09-26
WO1986004356A1 (fr)	1986-07-31
DE3650625D1 (de)	1997-06-26
DE3689598D1 (de)	1994-03-17
JPH082308B2 (ja)	1996-01-17
DE3689598T2 (de)	1994-06-30
FI94774C (fi)	1995-10-25
KR870700095A (ko)	1987-02-28
FI863891L (fi)	1986-09-26
EP0460709A1 (fr)	1991-12-11
EP0211047B1 (fr)	1994-02-02
JPH0767684A (ja)	1995-03-14
ATE101203T1 (de)	1994-02-15
NO863806L (no)	1986-11-19
DE3650625T2 (de)	1997-10-02
JPS62501538A (ja)	1987-06-25
NO863806D0 (no)	1986-09-24
EP0460709B1 (fr)	1997-05-21

Publication	Publication Date	Title
US5028530A (en)	1991-07-02	AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
US5206154A (en)	1993-04-27	Method of producing cecropins by microbiological techniques
NO175870B (fr)	1994-09-12
EP2088188B1 (fr)	2011-08-31	Expression directe des peptides dans un milieu de culture
JP2521413B2 (ja)	1996-08-07	シグナル配列をコ―ドしているｄｎａと直接結合しているヒト成長ホルモンをコ―ドしているｄｎａ
KR100316347B1 (ko)	2002-08-27	대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법
CN107099521B (zh)	2020-08-25	一种耐酸性玉米赤霉烯酮解毒酶及其编码基因与应用
EP0301078B1 (fr)	1995-05-10	Polypeptides presentant une activite contre les bacteries gram-positives et gram-negatives
HU210671B (en)	1995-06-28	Method for production of derivates of grocoth hormon
AU607973B2 (en)	1991-03-21	Process for production of physiologically active peptide containing cysteine residue
JP2970811B2 (ja)	1999-11-02	原核生物細胞中にポリペプチドを調製するための発現システム
JP2007501622A (ja)	2007-02-01	組換えポリペプチドを精製するための方法
Ohsuye et al.	1983	Expression of chemically synthesized α-neo-endorphin gene fused to E. coli alkaline phosphatase
JP2752092B2 (ja)	1998-05-18	Ｄｅｏプロモーターを有する発現プラスミド及び該プラスミドを含む細菌宿主
Wang et al.	1997	High‐level expression of cecropin CMIV in E. coli from a fusion construct containing the human tumor necrosis factor
Trepod et al.	2000	Modification of the carboxy-terminal amino acid sequence alters the Escherichia coli expression of a gene encoding multiple repeats of a bovine growth hormone releasing factor analog
JP2002511273A (ja)	2002-04-16	原核細胞における組換えタンパク質の制御発現のための新規な構築体
JPH0691833B2 (ja)	1994-11-16	利尿作用を有するポリペプチドの製造方法